Gene · 3134
Papers1,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single cell analysis reveals a subset of cytotoxic-like plasmacytoid dendritic cells in people with HIV-1. | iScience | 2023 | 37664600 | PubTator, text mining | PubMed |
| Decision trees to evaluate the risk of developing multiple sclerosis. | Front Neuroinform | 2023 | 37649987 | PubTator, text mining | PubMed |
| Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma. | PLoS One | 2023 | 37647275 | PubTator, text mining | PubMed |
| Single-cell RNA reveals a tumorigenic microenvironment in the interface zone of human breast tumors. | Breast Cancer Res | 2023 | 37644609 | PubTator, text mining | PubMed |
| Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment. | J Transl Med | 2023 | 37644433 | PubTator, text mining | PubMed |
| The complex HLA-E-nonapeptide in Behçet disease. | Front Immunol | 2023 | 37638008 | PubTator, text mining | PubMed |
| Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer. | Front Oncol | 2023 | 37637034 | PubTator, text mining | PubMed |
| Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS. | Cell Rep Med | 2023 | 37586319 | PubTator, text mining | PubMed |
| A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis. | Cancer Biol Ther | 2023 | 37548553 | PubTator, text mining | PubMed |
| Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma. | Blood Sci | 2023 | 37546707 | PubTator, text mining | PubMed |
| Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma. | Front Pharmacol | 2023 | 37538176 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related molecular subtypes and a novel predictive model of COVID-19 based on machine learning. | Front Immunol | 2023 | 37533853 | PubTator, text mining | PubMed |
| Prediction of Prognosis, Immunotherapy and Chemotherapy with an Immune-Related Risk Score Model for Endometrial Cancer. | Cancers (Basel) | 2023 | 37509334 | PubTator, text mining | PubMed |
| Insight of a lipid metabolism prognostic model to identify immune landscape and potential target for retroperitoneal liposarcoma. | Front Immunol | 2023 | 37483592 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals the clinical implications of myeloid-derived suppressor cells in head and neck squamous cell carcinoma. | Pathol Oncol Res | 2023 | 37475874 | PubTator, text mining | PubMed |
| Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector. | Nat Commun | 2023 | 37474509 | PubTator, text mining | PubMed |
| Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells. | Front Immunol | 2023 | 37435067 | PubTator, text mining | PubMed |
| Single-cell profiling reveals distinct immune response landscapes in tuberculous pleural effusion and non-TPE. | Front Immunol | 2023 | 37435066 | PubTator, text mining | PubMed |
| Novel microRNAs modulating ecto-5'-nucleotidase expression. | Front Immunol | 2023 | 37409119 | PubTator, text mining | PubMed |
| A human leukocyte antigen imputation study uncovers possible genetic interplay between gut inflammatory processes and autism spectrum disorders. | Transl Psychiatry | 2023 | 37407551 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3134/papers?page=8